When the WHO director general privately 'lost patience' with China


World Health Organization Director General Tedros Adhanom Ghebreyesus was perhaps not as soft on China during the pandemic as was previously thought, according to The Washington Post, per reporting from the upcoming novel Aftershocks: Pandemic Politics and the End of the Old International Order.
The book, written by Thomas Wright and Colin Kahl, details how Ghebreyesus "cautiously praised China in public while pressuring it in private," and in fact even "lost patience" with the country for attempting to influence COVID-19 origin probes, the Post reports.
When a WHO team in China reportedly twice dismissed the lab leak theory as "extremely unlikely" and "unworthy of further investigation," Ghebreyesus pushed back on the results, maintaining that the research was not "extensive enough" and lacked "timely and comprehensive data-sharing," writes the Post, per Wright and Kahl. The investigative team was reportedly "defensive" in their response, and mentioned "pressure from Chinese officials that led to a compromise."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
And since then, relations between the two entities have "nosedived." When the WHO team's official findings, released in March, repeated the lab leak theory to be extremely unlikely, Ghebreyesus told China's envoy in Geneva that he would tell the truth about the report "even if China did not like it," per Wright and Kahl.
But Ghebreyesus' soft public posture toward China was at odds with the stance taken by the administration of former President Donald Trump, who Wright claims "undermined" the lab leak theory by "taking it too far." "That U.S.-China rivalry really shaped everything else," he said. Read more at The Washington Post.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Earth's climate is in the era of 'global weirding'
The Explainer Weather is harder to predict and more extreme
By Devika Rao, The Week US Published
-
What is Kash Patel's net worth?
The Explainer The FBI Director has a number of unique revenue streams
By David Faris Published
-
TV to watch in March, including 'The Studio' and 'Paul American'
the week recommends A true crime story adaptation, a reality show about the ultra-American Paul brothers and a new late night series from John Mulaney
By Anya Jaremko-Greenwold, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published